
PulmCCM
1,361 FOLLOWERS
PulmCCM launched in 2012 as a solution to these related problems of information overload and journal fragmentation. And staying up to date in pulmonary & critical care is nearly impossible today in the traditional way. With hundreds of articles published in dozens of journals, we all miss important findings every month. PulmCCM helps doctors keep up with new findings in pulmonary & critical care.
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “… but prejudices, like odorous bodies, have a double existence, both solid and subtle – solid as the pyramids, subtle as the twentieth echo of an echo, or as the memory of hyacinths which once scented the darkness.” -Mary Ann Evans Background As previously described, the SARS-CoV-2 main protease inhibitor [Mpro] [... read more]
The post Nirmatrelvir-Ritonavir for ‘Standard Risk’ COVID-19 appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “When she smiles without her teeth in place she looks like a witch. But with them in her mouth she’s very pretty.” -Judy Blume Basic Biology The SARS-CoV-2 genome encodes structural proteins [i.e., spike, envelope, membrane, nucleocapsid] and polyproteins [i.e., pp1a and pp1ab]. When the guts of SARS-CoV-2 spew into a [... read more]
The post EPIC-HR Evaluates Nirmatrelvir-Ritonavir for COVID-19 appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “I find real life challenging enough. If I get to the dry cleaners without having a huge fight, that’s challenging enough.” -Fran Lebowitz Background Quite recently, the BaSICS investigators evaluated the infusion rate of a fluid bolus on patient outcome. As considered, however, contrast should be made between a fluid bolus, [... read more]
The post What Minimal Volume of Intravenous Fluid Challenges the Heart? appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “If you’re afraid of butter, use cream.” -Julia Child Background Early observational studies and the RECOVERY collaborative group initially demonstrated the benefit of corticosteroid therapy in oxygen-requiring, COVID-19-patients; additional randomized studies as well as a meta-analysis of these reports corroborated this. Yet the dosing of corticosteroids across the above studies was [... read more]
The post COVID STEROID 2 Trial Investigates Dexamethasone 6 mg or 12 mg in COVID-19 appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “It was after this realization that I began trying to find the ‘point’ of California, to locate some message in its history.” -Joan Didion Background A few months ago, I found myself in one of my favourite places – the American Museum of Natural History in New York City. Meandering through [... read more]
The post Fact-Checking Buffalo Chest appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “… Sartre tells us that man makes himself this lack of being in order that there might be being.” -Simone de Beauvoir Background Like many early, proposed therapies for COVID-19, inhaled corticosteroids [ICS] had suggestive, conflicting evidence. For example, in a very large observational investigation – the OpenSAFELY platform – patients with both [... read more]
The post PRINCIPLE Investigators Study Inhaled Budesonide for COVID-19 appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] About a decade ago, a handful of terrific reviews and investigations about phenylephrine – an alpha1 agonist – were published [1-3]. While this vasoactive medication might be thought only to ‘increase afterload,’ phenylephrine’s hemodynamic effects are knotty and noteworthy. Therefore, this dedicated dispatch delineates the difficulties encountered when predicting the hemodynamics [... read more]
The post ICU Physiology in 1000 Words: Phenylephrine Pushes & Stroke Volume appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] “In those years, truth was elusive – as was my own faith that I could recognize and contain it.” -Mary Oliver Previously, the very basic underpinnings of fluvoxamine as a pharmacological method to quell cytokine unruliness was outlined. In brief, fluvoxamine is a sigma-1-receptor [S1R] agonist – an effect that opposes [... read more]
The post The TOGETHER Trial Evaluates Fluvoxamine for COVID-19 appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] The left ventricular ejection fraction [LVEF] is a commonly-sought cardiac measure. With the explosion of bedside ultrasound and automated methods to capture LVEF, the ejection fraction will grow in clinical prominence and affect decisions for the acutely-ill. Asked the meaning of the LVEF, many clinicians might describe it as a ‘measure [... read more]
The post ICU Physiology in 1000 Words: The Geometry of Ejection Fraction appeared first on PulmCCM ..read more
PulmCCM
3y ago
Jon-Emile S. Kenny MD [@heart_lung] The relative simplicity of extending one’s finger onto the tissue overlaying a major artery belies the complicated forces generating an arterial pulse. Descriptions and physiological elucidations have been put forth across the decades, yet even today the machinations relating cardiac contraction to a waxing and waning arterial wall are a bit [... read more]
The post ICU Physiology in 1000 Words: The Pulse appeared first on PulmCCM ..read more